Menu
YUTIQ® (fluocinolone acetonide intravitreal implant) 0.18 mg is designed to be a long-lasting solution to posterior segment uveitis (in the back of the eye) for up to 36 months. Watch videos of patients like David explaining their journey with posterior segment uveitis and their YUTIQ treatment.
*People pictured are not real patients unless otherwise noted.
YUTIQ® (fluocinolone acetonide intravitreal implant) 0.18 mg contains a corticosteroid and is for the treatment of patients with chronic, non-infectious uveitis affecting the back of the eye.
Do not take YUTIQ if:
YUTIQ may cause serious side effects, including:
Injection-related effects, steroid-related effects and movement of the implant.
Call your doctor if your eye becomes red, sensitive to light, painful or if your vision changes or becomes blurred.
You may experience temporary blurred vision. Do not drive or use machines until your vision clears.
The most common side effects in the eye were cataract and reduced clarity of vision. The most common side effects not related to the eye were upper respiratory infection, high blood pressure and joint pain.
If you are pregnant, become pregnant or consider breastfeeding after having received YUTIQ inform your doctor immediately.
Please see full Prescribing Information.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800‑FDA‑1088.
YUTIQ, the YUTIQ logo, and the EyePoint logo are registered trademarks of EyePoint Pharmaceuticals, Inc. EyePoint Assist is a service mark of EyePoint Pharmaceuticals, Inc.
©2022 EyePoint Pharmaceuticals, Inc. All rights reserved.
480 Pleasant Street, Suite B300, Watertown, MA 02472
12/2022
US-YUT-2200116
YUTIQ® (fluocinolone acetonide intravitreal implant) 0.18 mg contains a corticosteroid and is for the treatment of patients with chronic, non-infectious uveitis affecting the back of the eye.
Do not take YUTIQ if:
